CIGNITI-TECHNOLOGIES
Cigniti Technologies Limited, India’s largest independent software testing services company, announced today, the acquisition of Gallop Solutions Inc, a US based specialized software testing services company. The combined entity is poised to become the world’s third largest independent software testing services company with revenues of $40 Million and more than 800 people worldwide. Cigniti Technologies is one of the fast growing IT services companies in this space and aims to become the world leader in software testing in the next few years through a combination of organic and inorganic growth.
Gallop specializes in building and implementing niche solutions in the Application Lifecycle Management (ALM) space with a special focus on Quality, Test Automation and Test Asset Modernization. Founded in 2009 by Manohar Reddy and Mahendra Alladi, Gallop Solutions is based in Irving, Texas in the US with an offshore technology center at Hyderabad, India. Gallop employs more than 200 people worldwide with 2012 revenues over $9.5 Million.
Speaking on this occasion Sriram Rajaram, President Strategy and Corporate Development, said, “Gallop Solutions is a great cultural fit for us and they have a fantastic team. This merger will add value to everyone concerned including shareholders, clients and employees. The combined revenues will take Cigniti past the $40 Million run rate and make us the world’s third largest independent testing services company. This will help our mission of becoming the world’s largest independent testing services company in the next few years. IP led testing is going to be a key driver of growth in the future and Gallop’s experience in delivering testing solutions around proprietary IP led products such as WinQuick and RoboQuick will add a lot of value to our clients and complement Cigniti’s SMART Tools.“
Manohar Reddy, CEO of Gallop Solutions, commented, “We are excited to be part of Cigniti which is recognized as a premier independent testing services company. Joining forces with a like-minded company in this domain should help us achieve our vision of becoming the world leader in software testing. Customers can expect the same level of drive and focus from the combined entity with further optimization in service delivery.”
Mahendra Alladi, Vice President of Technology and Professional Services at Gallop, commented, “Gallop’s IP led testing capabilities can reach a wider client base with the help of Cigniti’s investments in sales and marketing. Our testing tools expertise and solution driven approach perfectly complements Cigniti in maintaining the differentiation in the testing services space.”
About Cigniti : Cigniti Technologies Limited (BSE: 534758) is one of the world’s premier Independent Software Testing Services company. Over the last 15 years, Cigniti has improved quality of software for global Enterprises and Technology companies using proprietary SMART Tools and Cloud enabled Test Labs. Cigniti offers Test Consulting, Test Advisory services, Functional, Regression, Automation, Security, Performance, Enterprise Mobility, Cloud, Big Data and ERP testing services. Cigniti has strategic alliances with all the leading product, tool and technology vendors. Cigniti is the world’s first independent software testing services company rated at CMMI SVC1.3 maturity level and is an ISO27001:2005 certified organization.
For more information on Cigniti please visit http://www.cigniti.com .
Contact:
for Cigniti Technologies Limited
Lucy Dass
+ 91 90000 34653
lucy.dass@2020msl.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum